Swedish Chemicals Stock News

OM:JOMA
OM:JOMAReal Estate

3 Undervalued Small Caps In Global With Insider Buying

Amidst the backdrop of heightened Treasury yields and fluctuating investor sentiment, small-cap stocks have faced a challenging environment as evidenced by recent declines in indices like the S&P MidCap 400 and Russell 2000. However, these conditions can sometimes present opportunities for investors who are looking to identify undervalued companies with potential for growth. In this context, understanding market dynamics and insider activities can be crucial in evaluating promising small-cap...
OM:STOR B
OM:STOR BIndustrials

Storskogen Group (OM:STOR B) Could Be 23% Undervalued As Earnings Put Valuation In Focus

How the latest earnings put Storskogen Group in focus Storskogen Group (OM:STOR B) has drawn fresh attention after reporting second quarter 2026 results, with sales of SEK 8,861 million and net income of SEK 350 million from continuing operations. For the first half of 2026, the company reported sales of SEK 16,712 million and net income of SEK 496 million, giving investors an updated snapshot of profitability across its diversified portfolio. See our latest analysis for Storskogen...
OM:VSURE
OM:VSURECommercial Services

European Stocks Trading Below Estimated Value In August 2026

As European markets navigate the complexities of global bond sell-offs and inflationary pressures, investors are keenly observing opportunities within the region's equities. In this environment, identifying stocks that are trading below their estimated value can offer potential for growth, especially as economic indicators such as Germany's manufacturing momentum and improved eurozone activity provide a cautiously optimistic outlook.
OM:BURE
OM:BURECapital Markets

Bure Equity (OM:BURE) Could Be 77% Undervalued After Its Earnings Turnaround

Bure Equity (OM:BURE) reported a sharp turnaround in its second quarter and first half 2026 results, moving from prior period losses to positive revenue and net income, which has drawn fresh attention to the stock. See our latest analysis for Bure Equity. The strong Q2 rebound in Bure Equity's earnings appears to be feeding into sentiment, with the share price at SEK298.6 and a year-to-date share price return of 25.15%, alongside a 3-year total shareholder return of 42.00%. This suggests...
OM:LATO B
OM:LATO BIndustrials

How Investors Are Reacting To Investment AB Latour (OM:LATO B) Q2 Profitability Surging Despite Modest Sales Growth

In August 2026, Investment AB Latour (publ) reported second-quarter 2026 results showing sales of SEK 7,225 million and net income of SEK 3,647 million, with basic earnings per share from continuing operations of SEK 5.7. An interesting aspect of the report is that while second-quarter sales rose only slightly year on year, net income and earnings per share from continuing operations more than doubled over the same period, highlighting a strong improvement in profitability. With these robust...
OM:EMBRAC B
OM:EMBRAC BEntertainment

How Investors Are Reacting To Embracer Group (OM:EMBRAC B) Return To Profitability And Higher Cash EBIT Targets

In August 2026, Embracer Group AB (publ) reported first-quarter revenue of SEK 4,006 million and net income of SEK 39 million, compared with revenue of SEK 3,261 million and a net loss of SEK 411 million a year earlier, and issued guidance targeting at least SEK 1.00 billion in Cash EBIT for fiscal 2026–27. The shift from loss to profit, combined with management’s expectation of year-on-year Cash EBIT improvement similar to the first quarter, marks a meaningful milestone in Embracer’s...
OM:SYNSAM
OM:SYNSAMSpecialty Retail

Synsam (OM:SYNSAM) Stock Nears Value Debate After Strong Q2 Growth

Synsam went into this Q2 print with momentum and a stock at SEK60.2, up around 11% over the past three months. The market has been treating it as a solid growth story in Nordic optical retail. Today's headline is simple: earnings and cash generation looked strong, with Q2 basic EPS at 1.35 SEK on revenue of SEK2,081m, and the trailing P/E of 14.8x still sits well below the peer average of 36.2x. The gap between share price and the implied fair value estimate remains wide, which keeps the...
OM:EGTX
OM:EGTXBiotechs

Egetis Therapeutics (OM:EGTX) Stock Can Emcitate Justify Mounting Losses?

Egetis Therapeutics stock closed at SEK7.33 on the day of its Q2 report, after a steady 7 day climb of about 2% and a 3 month gain of about 16%. The headlines, however, sit squarely on the income statement. The company booked revenue of SEK17.4m for the quarter while posting a net loss of SEK108.9m as it pours money into Emcitate ahead of a potential United States launch. In the very short term that loss looks heavy. Through a longer lens the key debate is whether today’s cash burn and high...
OM:PAX
OM:PAXMedical Equipment

Paxman (OM:PAX) Profit Turn Sharpens Focus On Reimbursement Growth

Paxman stock closed at SEK55.0 on 21 August, capping a strong run over the past month. Yet the real story sits in the earnings rather than the chart. Q2 group revenue reached about SEK107.6m and the company reported a profit of SEK2.6m of net income from ongoing operations. That shift from loss making into the black is the single number long term holders will care about. Short term traders are reacting to momentum. Longer term investors are now asking whether this first profitable quarter can...
OM:NIBE B
OM:NIBE BBuilding

NIBE Industrier (OM:NIBE B) Stock Jumps As Margins Recover And Valuation Debate Deepens

NIBE Industrier stock came into this Q2 print with the wind at its back, up about 9.7% over the past week and 12.9% over the past month, and closed today at SEK41.99. The headline from the numbers is clear for a heating and electrification specialist. Revenue reached SEK10,849m in Q2 and net income landed at SEK751m, supported by visibly stronger performance in Climate Solutions and Element, while Stoves remained the weak spot. The gap for investors is between a market already pricing in...